Patrick T. Higgins
Direttore/Membro del Consiglio presso Antios Therapeutics, Inc.
Profilo
Patrick T.
Higgins was the founder of Arbutus Biopharma, Inc. founded in 2012, where he held the title of Chief Executive Officer & Director.
Currently, he is a Director at Antios Therapeutics, Inc. since 2021.
Previously, he held the position of Vice President of Sales & Marketing at Roche Pharmaceuticals, Inc. and Executive Vice President-Marketing & Sales at Pharmasset, Inc. from 2007 to 2012.
He was also the Chief Operating & Business Officer at Arbutus Biopharma Corp.
and Vice President-Sales, Marketing & Virology at Hoffmann-La Roche, Inc. from 1995 to 2006.
Additionally, he was the President of SRX By RX Consulting, Inc. Mr. Higgins holds an MBA from Seton Hall University and an undergraduate degree from Villanova University.
Posizioni attive di Patrick T. Higgins
| Società | Posizione | Inizio |
|---|---|---|
Antios Therapeutics, Inc.
 Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Direttore/Membro del Consiglio | 11/02/2021 |
Precedenti posizioni note di Patrick T. Higgins
| Società | Posizione | Fine |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Direttore operativo | 30/04/2016 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Vendite & Marketing | 13/01/2012 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Vendite & Marketing | 01/01/2006 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Vendite & Marketing | - |
| SRX By RX Consulting, Inc. | Presidente | - |
Formazione di Patrick T. Higgins
| Seton Hall University | Masters Business Admin |
| Villanova University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| Aziende private | 6 |
|---|---|
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
| SRX By RX Consulting, Inc. | |
Antios Therapeutics, Inc.
Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Health Technology |
- Borsa valori
- Insiders
- Patrick T. Higgins
